ProMIS Neurosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Tables)

FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Mar. 31, 2023

FAIR VALUE MEASUREMENTS

Summary of major categories of assets and liabilities measured at fair value on a recurring basis


		As of March 31, 2023
		Level 1			Level 2				Level 3		Total
Assets:
Short-term investments		$	31,134		$	—		$	—		$	31,134
Total assets measured at fair value		$	31,134		$	—		$	—		$	31,134
Liabilities:
Warrant liability			—			—			1,901,722			1,901,722
Total liabilities measured at fair value		$	—		$	—		$	1,901,722		$	1,901,722


		As of December 31, 2022
		Level 1			Level 2			Level 3			Total
Assets:
Short-term investments		$	31,009		$	—		$	—		$	31,009
Total assets measured at fair value		$	31,009		$	—		$	—		$	31,009
Liabilities:
Warrant liability			—			—			1,859,374			1,859,374
Total liabilities measured at fair value		$	—		$	—		$	1,859,374		$	1,859,374